Tuesday, May 9, 2017

BRIEF-Pulmatrix says received key patent in U.S. For PUR0200

* Received key patent in U.S. for its lead drug candidate, PUR0200, which is intended to treat chronic obstructive pulmonary diseases

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)